| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/24/2005 | US20050063994 administering microorganisms that contain a recombinant version of the protein allergen to allergic subjects; antiallergens |
| 03/24/2005 | US20050063993 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering |
| 03/24/2005 | US20050063988 Containing a hybrid fusion polypeptide that includes a multivalent immunogenic portion of at least two immunogenic polypeptides from Group A streptococci M proteins and a carboxy-terminal reiterated immunogenic polypeptide |
| 03/24/2005 | US20050063987 Proteins, in particular membrane proteins, of Helicobacter pylori, their preparation and use |
| 03/24/2005 | US20050063986 Process for the preparation of non-toxic anthrax vaccine |
| 03/24/2005 | US20050063985 Method and compositions for immunization with the pseudomonas v antigen |
| 03/24/2005 | US20050063984 Antigenic peptide fragments of vapa protein, and uses thereof |
| 03/24/2005 | US20050063982 GRP94-based compositions and methods of use thereof |
| 03/24/2005 | US20050063979 Budded from a plasma membrane of a eukaryotic cell upon transfection with viral gene sequences, and have surface molecules for antigen-specific activation or deactivation of T lymphocytes |
| 03/24/2005 | US20050063978 With a carrier peptide adjuvant that is able to strongly enhance the immune response to a specific co-administered antigen |
| 03/24/2005 | US20050063977 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 03/24/2005 | US20050063976 Combination therapy for treating disease |
| 03/24/2005 | US20050063975 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents |
| 03/24/2005 | US20050063971 Monoclonal or humanized antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, polypeptide fragment, polynucleotide or antibody |
| 03/24/2005 | US20050063970 An immunomolecule containing a soluble human Major Histocompatibility Complex class I effector domain linked to an antibody targeting domain; immunotherapy; anticarcinogenic agents |
| 03/24/2005 | US20050063969 Assay |
| 03/24/2005 | US20050063952 Immunogenic CEA |
| 03/24/2005 | US20050063947 Method for treating cancer in humans |
| 03/24/2005 | DE10339966A1 Immunogenic constructs for inducing antiviral neutralizing antibodies in humans and animals, comprises selected amino acid sequences from specified locations of envelope proteins |
| 03/24/2005 | DE10339927A1 Zusammensetzung zur Prophylaxe/Therapie von HBV-Infektionen und HBV-vermittelten Erkrankungen A composition for prophylaxis / therapy of HBV infection and HBV-mediated diseases |
| 03/24/2005 | CA2578375A1 Vaccine immunotherapy for immune suppressed patients |
| 03/24/2005 | CA2539300A1 Inhibitors of pace4 for the treatment of arthritis |
| 03/24/2005 | CA2539000A1 Combination of a histone deacetylase inhibitor with a death receptor ligand |
| 03/24/2005 | CA2538895A1 Factor ixa specific antibodies displaying factor viiia like activity |
| 03/24/2005 | CA2538763A1 Monoclonal antibodies against hmgb1 |
| 03/24/2005 | CA2538754A1 Inhibition of inward sodium currents in cancer |
| 03/24/2005 | CA2538495A1 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 03/24/2005 | CA2538442A1 Eukaryotic genes for modulating cell cycle progression |
| 03/24/2005 | CA2538229A1 Treatment of rheumatoid arthritis with cd99 antagonists |
| 03/24/2005 | CA2538220A1 Use of antibody |
| 03/24/2005 | CA2538197A1 Improvements in vaccination |
| 03/24/2005 | CA2538076A1 Monoclonal antibodies specific for conformational epitopes of prefibrillar aggregates |
| 03/24/2005 | CA2537931A1 Multi-antigen vectors for melanoma |
| 03/24/2005 | CA2537489A1 Vaccines |
| 03/24/2005 | CA2537429A1 Method and device for detecting feline immunodeficiency virus |
| 03/24/2005 | CA2537360A1 Methods and compositions for treating herpes infections |
| 03/24/2005 | CA2537217A1 Therapeutic binding molecules |
| 03/24/2005 | CA2536989A1 Lawsonia intracellularis subunit vaccine |
| 03/24/2005 | CA2536396A1 Methods of using wisp antagonists |
| 03/24/2005 | CA2533926A1 Methods and compositions for producing antigenic responses |
| 03/24/2005 | CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/23/2005 | WO2005030935A2 Adjuvant activities of mutants of lt-iia and lt-iib enterotoxin lacking binding to ganglioside |
| 03/23/2005 | EP1516932A1 Poxvirus with targeted infection specificity |
| 03/23/2005 | EP1516930A1 Cellular model of tauopathies for lead identification and drug discovery |
| 03/23/2005 | EP1516881A2 Composition and method for modulating dendritic Cell-T cell interaction |
| 03/23/2005 | EP1516628A1 Stable isotonic lyophilized protein formulation |
| 03/23/2005 | EP1516185A2 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 03/23/2005 | EP1516179A1 Methods and compositions for the diagnosis and treatment of demyelinating inflammatory disorders |
| 03/23/2005 | EP1516064A2 Methods of using 46828, a human acyl-coa synthetase |
| 03/23/2005 | EP1516049A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/23/2005 | EP1515988A1 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 03/23/2005 | EP1515982A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 03/23/2005 | EP1515750A1 Combinations comprising epothilones and pharmaceutical uses thereof |
| 03/23/2005 | EP1515749A1 Combined use of a modulator of cd3 and a glp-1 compound |
| 03/23/2005 | EP1515747A2 Immunogenic agent therapy using plasmapheresis or exchange transfusion |
| 03/23/2005 | EP1515743A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 03/23/2005 | EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 03/23/2005 | EP1515738A2 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins |
| 03/23/2005 | EP1515724A1 Mitotic kinesin inhibitors |
| 03/23/2005 | EP1515707A2 Method of treating atherosclerosis and other inflammatory diseases |
| 03/23/2005 | EP1401871B1 Immunological binding molecules inhibiting the syncytial fusion of trophoblast cells |
| 03/23/2005 | EP1357937B1 Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology |
| 03/23/2005 | EP1345618B1 Chlorzoxazone for the treatment of psoriasis |
| 03/23/2005 | EP1328540B1 Immunoreactive peptidic ctl epitopes of human cytomegalovirus pp150 |
| 03/23/2005 | EP1228373B1 Diagnosis and therapy of cancer using sgp28-related molecules |
| 03/23/2005 | EP1114166B1 Method for down-regulating osteoprotegerin ligand activity |
| 03/23/2005 | EP0981636B1 Lentivirus-based gene transfer vectors |
| 03/23/2005 | EP0968297B1 Live recombinant avian vaccine using the avian infectious laryngotracheitis virus as vector |
| 03/23/2005 | EP0832241B1 Mutants of streptococcal toxin a and methods of use |
| 03/23/2005 | EP0804613B1 Dap-2 tumor suppressor gene, protein encoded thereby and use of said gene and protein |
| 03/23/2005 | EP0662092B1 Activity-dependent neurotrophic factor |
| 03/23/2005 | EP0574579B1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 03/23/2005 | CN1599794A Production of viruses, viral isolates and vaccines |
| 03/23/2005 | CN1599755A Antibodies against caspase-8, their preparation and use |
| 03/23/2005 | CN1599750A Cytotoxic protein and utilization thereof |
| 03/23/2005 | CN1599746A Adjuvanted meningococcus compositions |
| 03/23/2005 | CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists |
| 03/23/2005 | CN1599623A Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 03/23/2005 | CN1598585A Molecular sieve separation monoclonal antibody blood testing method and kit |
| 03/23/2005 | CN1598582A Pesticide sevin artificial antigen and antibody and preparation method and application thereof |
| 03/23/2005 | CN1597956A Trans menbrance type and secretory type HIV Gag antigen code gene and AIDS vaccine containing said gene |
| 03/23/2005 | CN1597953A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 03/23/2005 | CN1597950A Icam-4 materials and methods |
| 03/23/2005 | CN1597694A Meningococcal antigens |
| 03/23/2005 | CN1597693A Antigen analogue epi-peptide of para bacillus fowl blood phili and its use |
| 03/23/2005 | CN1596985A New clinical parameters for determining haematics toxicity prior to radioimmunotherapy |
| 03/23/2005 | CN1596980A AntiAids sexual contact protective agent and its production method |
| 03/23/2005 | CN1596979A Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 03/23/2005 | CN1596978A Combined vaccine for hepatitis A, B virus and its preparation method |
| 03/23/2005 | CN1596977A Anti gonadoliberin resisting hormone nucleic acid vaccine and its preparation method |
| 03/23/2005 | CN1596976A Polypeptide vaccine capable of effectively preventing pointed condyloma |
| 03/23/2005 | CN1194017C Novel antibody, renin-active substance containing same and prorenin assay reagent using the same |
| 03/23/2005 | CN1194016C New human chorionic gonadotropin-lutropin fusion protein and its prepn and use |
| 03/23/2005 | CN1194008C Recombination main outer membrane protein of parrot fever chlaydozoan, and preparation process and use thereof |
| 03/23/2005 | CN1194005C Producing influenza killed vaccine by Sepharose 4FF column chromatography technology |
| 03/23/2005 | CN1193791C Ordered molecualr presentation of antigens. method of preparation and use |
| 03/22/2005 | US6870042 Mutants of streptococcal toxin A and methods of use |
| 03/22/2005 | US6870032 Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirus in hexameric form |
| 03/22/2005 | US6870030 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders |
| 03/22/2005 | US6870027 Expression of PUMP-1 protease (matrix metalloprotease 7) and the detected proteases are themselves specifically over-expressed in certain cancer, so their presence may serve for early detection of associated ovarian cancer |